Atlas Trials

Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma

Clinical trial NCT02652715 · COMPLETED

Trial details

NCT number
NCT02652715
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Adult Nasal Type Extranodal NK/T-Cell LymphomaAdult T-Cell Leukemia/LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-Cell LymphomaB Lymphoblastic Leukemia/LymphomaBlastic Plasmacytoid Dendritic Cell NeoplasmBurkitt LeukemiaCentral Nervous System LymphomaChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaDiffuse Large B-Cell LymphomaEnteropathy-Associated T-Cell LymphomaExtranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
Start date
2016-01-19
Primary completion
2018-12-21
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.